HuGE Literature Finder
Records
1
-
8
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
Targeted Sequencing of Ascites and Peritoneal Washing Fluid of Patients With Gastrointestinal Cancers and Their Clinical Applications and Limitations. Frontiers in oncology 2021 11 712754. Bae Go Eun, Kim Seok-Hwan, Choi Min Kyung, Kim Jin-Man, Yeo Min-Kyu |
APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors. Oncology letters 2016 Sep 12 (3): 2210-2216. Ginesta Mireia M, Diaz-Riascos Zamira Vanessa, Busquets Juli, Pelaez Núria, Serrano Teresa, Peinado Miquel Àngel, Jorba Rosa, García-Borobia Francisco Javier, Capella Gabriel, Fabregat Jo |
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology 2015 Mar 148 (3): 556-64. Grant Robert C, Selander Iris, Connor Ashton A, Selvarajah Shamini, Borgida Ayelet, Briollais Laurent, Petersen Gloria M, Lerner-Ellis Jordan, Holter Spring, Gallinger Stev |
Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk. Molecular carcinogenesis 2013 Nov 52 Suppl 1 E103-9. Jang Ji-Hyun, Cotterchio Michelle, Borgida Ayelet, Liu Geoffrey, Gallinger Steven, Cleary Sean |
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer. Cancer chemotherapy and pharmacology 2013 Jan 71 (1): 85-92. Takahara Naminatsu, Nakai Yousuke, Isayama Hiroyuki, Sasaki Takashi, Satoh Yumiko, Takai Daiya, Hamada Tsuyoshi, Uchino Rie, Mizuno Suguru, Miyabayashi Koji, Mohri Dai, Kawakubo Kazumichi, Kogure Hirofumi, Yamamoto Natsuyo, Sasahira Naoki, Hirano Kenji, Ijichi Hideaki, Tada Minoru, Yatomi Yutaka, Koike Kazuhi |
Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1. Couch FJ, Wang X, Bamlet WR, de Andrade M, Petersen GM, McWilliams RR |
CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome. PloS one 0 10 (9): e0134469. Shamai Sivan, Nabiochtchikov Ilana, Kraus Sarah, Zigdon Sally, Kazanov Dina, Itzhak-Klutch Michal, Eizner Carmit, Arber Nadir, Geva Rav |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: